19 | ResveratrolIBA
03/2015
-
03/2005 |
15 | Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2017
-
08/2002 |
14 | Cytarabine (Cytosar-U)FDA LinkGeneric
10/2017
-
08/2002 |
7 | DNA (Deoxyribonucleic Acid)IBA
01/2018
-
03/2005 |
7 | Pharmaceutical PreparationsIBA
10/2017
-
04/2002 |
6 | Hormones (Hormone)IBA
10/2021
-
09/2007 |
6 | EnzymesIBA
10/2013
-
04/2002 |
4 | Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2011
-
01/2007 |
4 | StilbenesIBA
06/2010
-
10/2006 |
4 | 3,3',4,4',5,5'-hexahydroxystilbeneIBA
06/2010
-
09/2006 |
4 | Floxuridine (FUdR)FDA LinkGeneric
07/2005
-
09/2003 |
3 | Gallic AcidIBA
01/2018
-
01/2007 |
3 | Antineoplastic Agents (Antineoplastics)IBA
10/2017
-
04/2002 |
3 | Proteins (Proteins, Gene)FDA Link
08/2015
-
10/2009 |
3 | digalloylresveratrolIBA
10/2013
-
02/2009 |
3 | Phosphates (Orthophosphate)IBA
06/2012
-
08/2004 |
3 | 3,3',4,5'-tetrahydroxystilbeneIBA
12/2010
-
09/2006 |
3 | AvemarIBA
03/2009
-
02/2005 |
3 | AntioxidantsIBA
08/2008
-
09/2006 |
2 | C-Reactive ProteinIBA
12/2021
-
01/2020 |
2 | ReninIBA
12/2021
-
10/2021 |
2 | AldosteroneIBA
12/2021
-
10/2021 |
2 | Biomarkers (Surrogate Marker)IBA
10/2021
-
01/2020 |
2 | Brain Natriuretic Peptide (Natrecor)FDA Link
10/2021
-
10/2007 |
2 | Natriuretic PeptidesIBA
10/2021
-
10/2007 |
2 | pro-brain natriuretic peptide (1-76)IBA
10/2021
-
01/2009 |
2 | Anaplastic Lymphoma KinaseIBA
08/2015
-
01/2015 |
2 | Messenger RNA (mRNA)IBA
08/2015
-
03/2010 |
2 | PolyphenolsIBA
01/2015
-
10/2009 |
2 | triphosphoric acid (triphosphate)IBA
01/2015
-
12/2010 |
2 | Sulfates (Sulfates, Inorganic)IBA
09/2014
-
03/2010 |
2 | GemcitabineFDA Link
11/2012
-
02/2008 |
2 | Estrogens (Estrogen)FDA Link
09/2012
-
12/2010 |
2 | Biological ProductsIBA
06/2011
-
09/2007 |
2 | SulfotransferasesIBA
03/2010
-
03/2008 |
2 | CytidineIBA
02/2009
-
03/2005 |
2 | Fluorouracil (Carac)FDA LinkGeneric
02/2009
-
08/2004 |
2 | 3'-C-methyladenosineIBA
07/2008
-
07/2005 |
2 | Deuterium Oxide (Heavy Water)IBA
02/2008
-
09/2005 |
2 | 3,4,5-trihydroxybenzamidoximeIBA
02/2006
-
08/2002 |
2 | tiazofurinIBA
03/2005
-
04/2002 |
2 | Carmustine (FIVB)FDA Link
10/2004
-
08/2004 |
2 | 3,4-dihydroxybenzohydroxamic acidIBA
10/2004
-
08/2004 |
2 | 3-(1-deoxyribofuranosyl)benzamideIBA
04/2002
-
04/2002 |
1 | PlasminogenIBA
12/2021 |
1 | Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2021 |
1 | Prothrombin (Factor II)IBA
12/2021 |
1 | AntigensIBA
12/2021 |
1 | fibrin fragment D (D-dimer)IBA
12/2021 |
1 | Antifibrinolytic Agents (Antifibrinolytics)IBA
12/2021 |
1 | Interleukin-6 (Interleukin 6)IBA
12/2021 |
1 | von Willebrand FactorIBA
12/2021 |
1 | Arginine Vasopressin (Argipressin)IBA
10/2021 |
1 | AngiotensinsIBA
10/2021 |
1 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 |
1 | LeptinIBA
01/2020 |
1 | AdipokinesIBA
01/2020 |
1 | AdiponectinIBA
01/2020 |
1 | omega-Chloroacetophenone (Mace)IBA
01/2019 |
1 | Phospholipases (Phospholipase)IBA
01/2019 |
1 | TroponinIBA
01/2019 |